Reduced Elective Nodal Dose
Showing 1 - 25 of >10,000
Anal Cancer Trial in Cincinnati (Radiation (reduced elective nodal dose (30.6 Gy), Capecitabine, Mitomycin c)
Not yet recruiting
- Anal Cancer
- Radiation (reduced elective nodal dose (30.6 Gy)
- +2 more
-
Cincinnati, OhioUniversity of Cincinnati Medical Center
Jun 5, 2023
Head Neck Cancer, Oropharynx Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Columbia (Cisplatin injection)
Recruiting
- Cancer of the Head and Neck
- +3 more
- Cisplatin injection
-
Columbia, MissouriUniversity of Missouri
Oct 31, 2022
Head and Neck Squamous Cell Carcinoma Trial in Dallas (Intensity modulated radiation therapy (IMRT))
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- Intensity modulated radiation therapy (IMRT)
-
Dallas, TexasUniversity of Texas Southwestern Medical Center - Dallas
Nov 18, 2022
Head Neck Cancer, Oropharynx Cancer, Oropharyngeal Squamous Cell Carcinoma Trial in United States (Intensity modulated
Recruiting
- Head and Neck Cancer
- +2 more
- Intensity modulated radiotherapy (IMRT)/volumetric modulated arc therapy (VMAT) or Pencil beam proton therapy (PBPT)
-
Baltimore, Maryland
- +5 more
Apr 26, 2022
Uterine Cervical Tumors Trial in Vienna (radiation, drug, other)
Recruiting
- Uterine Cervical Neoplasms
- Increased use of IC/IS technique in BT
- +8 more
-
Vienna, AustriaMedical University of Vienna
Mar 1, 2022
Head and Neck Carcinoma Trial in Cairo (Elective nodal de-escalation arm)
Recruiting
- Head and Neck Carcinoma
- Elective nodal de-escalation arm
-
Cairo, EgyptNational Cancer Institute
Dec 6, 2022
Pancreatic Cancer Trial in Jacksonville, Warrenville, Fairfax (radiation, drug, procedure)
Recruiting
- Pancreatic Cancer
- Proton Radiation
- +2 more
-
Jacksonville, Florida
- +2 more
Oct 24, 2021
Squamous Cell Carcinoma of Head and Neck Trial in Belgium (Dose de-escalation and / or Volume de-escalation)
Recruiting
- Squamous Cell Carcinoma of Head and Neck
- Dose de-escalation and / or Volume de-escalation
-
Brussel, Belgium
- +3 more
Jan 25, 2022
Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx
Not yet recruiting
- Squamous Cell Carcinoma of the Oral Cavity
- +3 more
- Eliminating RT to the elective neck
- RT standard of care
-
Erlangen, Bavaria, GermanyUniversitätsklinikum Erlangen, Strahlenklinik
Sep 8, 2023
Head Neck Cancer Trial in Amsterdam (Unilateral elective nodal irradiation)
Recruiting
- Head and Neck Cancer
- Unilateral elective nodal irradiation
-
Amsterdam, NetherlandsNetherlands Cancer Institute
Jan 20, 2022
Head and Neck Squamous Cell Carcinoma, Hypofractionation, Radiotherapy Trial (HYpofractionated, Dose-redistributed RAdiotherapy
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +4 more
- HYpofractionated, Dose-redistributed RAdiotherapy (HYDRA)
- conventional fractionated radiotherapy
-
Rotterdam, Zuid Holland, NetherlandsErasmus MC
Dec 7, 2022
Human Papillomavirus-Related Carcinoma, Oropharyngeal Cancer Trial in Dallas (Hypofractionated intensity modulated radiotherapy)
Recruiting
- Human Papillomavirus-Related Carcinoma
- Oropharyngeal Cancer
- Hypofractionated intensity modulated radiotherapy
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Dec 14, 2021
Breast Tumors, Radiotherapy, Lymph Node Metastases Trial in Ghent (Prone Radiotherapy, Acceleration, Supine Radiotherapy)
Completed
- Breast Neoplasms
- +2 more
- Prone Radiotherapy
- +3 more
-
Ghent, Oost-Vlaanderen, BelgiumRadiotherapy department, UZ Ghent
Dec 9, 2022
Uterine Cervical Tumor Trial in Beijing (online adaptive radiotherapy)
Recruiting
- Uterine Cervical Neoplasm
- online adaptive radiotherapy
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 19, 2023
Prostatic Tumors, Radiosurgery, Quality of Life Trial in Santiago (External beam image guided radiotherapy)
Recruiting
- Prostatic Neoplasms
- +2 more
- External beam image guided radiotherapy
-
Santiago, Metropolitana, ChilePontificia Universidad Catolica de Chile
Nov 5, 2021
Head and Neck Melanoma Trial in New York (fluorescent cRGDY-PEG-Cy5.5-C dots)
Recruiting
- Head and Neck Melanoma
- fluorescent cRGDY-PEG-Cy5.5-C dots
-
New York, New York
- +1 more
Nov 23, 2022
Oropharyngeal Squamous Cell Carcinoma (OPSCCA), HPV (Human Papillomavirus)-Associated Trial in Charlottesville (39.6 Gy
Completed
- Oropharyngeal Squamous Cell Carcinoma (OPSCCA)
- HPV (Human Papillomavirus)-Associated
- 39.6 Gy radiation
-
Charlottesville, VirginiaUniversity of Virginia Health System
Oct 9, 2018
Nasopharyngeal Carcinoma Trial in Beijing (intensity-modulated radiotherapy (IMRT) with reduced-volume, Cisplatin (DDP))
Not yet recruiting
- Nasopharyngeal Carcinoma
- intensity-modulated radiotherapy (IMRT) with reduced-volume
- Cisplatin (DDP)
-
Beijing, ChinaCancer hospital, Chinese Academy of Medical Sciences
Nov 22, 2021
Esophageal Squamous Cell Carcinoma Trial in Tokyo (Chemoradiotherapy)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Chemoradiotherapy
-
Tokyo, JapanNational Cancer Center Hospital
Apr 5, 2022
Pancreatic Adenocarcinoma Trial in Dublin (Dose-Painted Intensity Modulated Radiotherapy)
Not yet recruiting
- Pancreatic Adenocarcinoma
- Dose-Painted Intensity Modulated Radiotherapy
-
Dublin, IrelandSt Luke's Radiation Oncology Network (SLRON)
Aug 29, 2023
Pancreas Cancer, Pancreatic Adenocarcinoma Trial in Verona (Systematic lymphadenectomy)
Recruiting
- Pancreas Cancer
- Pancreatic Adenocarcinoma
- Systematic lymphadenectomy
-
Verona, VR, ItalyUnit of Pancreatic Surgery - G.B. Rossi Hospital, University of
Nov 15, 2023
Axillary Ultrasound to Guide Breast Cancer Management in Genomic
Active, not recruiting
- Axillary Ultrasound
- axillary ultrasound
-
Singapore, SingaporeKK Women's and Children's Hospital
Sep 12, 2023
Hemorrhage, Postpartum, Placenta Previa Trial in Guangzhou (Tranexamic acid, 0.9% sodium chloride)
Not yet recruiting
- Hemorrhage, Postpartum
- Placenta Previa
- Tranexamic acid
- 0.9% sodium chloride
-
Guangzhou, Guangdong, ChinaDepartment of Obstetrics and Gynecology, The Third Affiliated Ho
Apr 12, 2023
Squamous Cell Carcinoma of the Head and Neck T1/2N0-2 Trial in Dallas (Intensity Modulated Radiotherapy)
Terminated
- Squamous Cell Carcinoma of the Head and Neck T1/2N0-2
- Intensity Modulated Radiotherapy
-
Dallas, TexasUniversity of Texas at Southwestern Medical Center
Jan 28, 2021